NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication

Area of Science:

• Immunology
• Virology
• Hepatology

Background:

• Type I interferon (IFN-I) therapy is used for Hepatitis B virus (HBV) infection but has low response rates and side effects.
• Understanding the molecular mechanisms of IFN-I therapy in HBV is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the interaction between HBV and IFN-induced proteins with tetratricopeptide repeats (IFITs).
• To elucidate the role of IFITs in HBV replication during IFN-I therapy.

Main Methods:

• Analysis of IFIT expression in peripheral blood mononuclear cells (PBMCs) from HBV patients on IFN-I therapy.
• Transfection of hepatic cells with HBV plasmid and assessment of IFIT expression.
• Investigation of HBx protein's role in IFIT3 transcription via NF-κB pathway.
• Overexpression of IFIT3 in HepG2 cells to evaluate its effect on HBV replication.

Main Results:

• Elevated IFIT expression was observed in PBMCs of HBV patients undergoing IFN-I therapy.
• IFIT1, IFIT2, and IFIT3 expression increased in cells transfected with an HBV plasmid.
• HBx protein activates NF-κB, leading to direct IFIT3 transcription.
• Overexpression of IFIT3 enhanced HBV replication in HepG2 cells.

Conclusions:

• IFIT genes, unexpectedly, may promote viral replication in HBV.
• IFIT genes represent potential therapeutic targets for improving HBV treatment efficacy.